{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,5,29]],"date-time":"2023-05-29T20:27:18Z","timestamp":1685392038596},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2013,8,31]],"date-time":"2013-08-31T00:00:00Z","timestamp":1377907200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Naunyn-Schmiedeberg's Arch Pharmacol"],"published-print":{"date-parts":[[2013,12]]},"DOI":"10.1007\/s00210-013-0910-z","type":"journal-article","created":{"date-parts":[[2013,8,30]],"date-time":"2013-08-30T04:35:29Z","timestamp":1377837329000},"page":"1095-1102","source":"Crossref","is-referenced-by-count":1,"title":["Imidafenacin has no influence on learning in nucleus basalis of Meynert-lesioned rats"],"prefix":"10.1007","volume":"386","author":[{"given":"Takanobu","family":"Yamazaki","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ayako","family":"Fukata","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2013,8,31]]},"reference":[{"key":"910_CR1","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1111\/j.1464-410X.2007.07205.x","volume":"100","author":"P Abrams","year":"2007","unstructured":"Abrams P, Andersson KE (2007) Muscarinic receptor antagonists for overactive bladder. BJU Int 100:987\u20131006","journal-title":"BJU Int"},{"key":"910_CR2","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1002\/nau.10052","volume":"21","author":"P Abrams","year":"2002","unstructured":"Abrams P, Cardozo L, Fall M, Griffiths D, Rosier P, Ulmsten U, van Kerrebroeck P, Victor A, Wein A, Standardisation Sub-committee of the International Continence Society (2002) The standardisation of terminology of lower urinary tract function: report from the Standardisation Sub-committee of the International Continence Society. Neurourol Urodyn 21:167\u2013178","journal-title":"Neurourol Urodyn"},{"key":"910_CR3","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1038\/sj.bjp.0706780","volume":"148","author":"P Abrams","year":"2006","unstructured":"Abrams P, Andersson KE, Buccafusco JJ, Chapple C, de Groat WC, Fryer AD, Kay G, Laties A, Nathanson NM, Pasricha PJ, Wein AJ (2006) Muscarinic receptors: their distribution and function in body systems, and the implications for treating overactive bladder. Br J Pharmacol 148:565\u2013578","journal-title":"Br J Pharmacol"},{"key":"910_CR4","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1007\/BF00210833","volume":"92","author":"TG Aigner","year":"1987","unstructured":"Aigner TG, Mitchell SJ, Aggleton JP, DeLong MR, Struble RG, Price DL, Wenk GL, Mishkin M (1987) Effects of scopolamine and physostigmine on recognition memory in monkeys with ibotenic-acid lesions of the nucleus basalis of Meynert. Psychopharmacol (Berl) 92:292\u2013300","journal-title":"Psychopharmacol (Berl)"},{"key":"910_CR5","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1111\/j.1365-2125.2011.03961.x","volume":"72","author":"E Callegari","year":"2011","unstructured":"Callegari E, Malhotra B, Bungay PJ, Webster R, Fenner KS, Kempshall S, LaPerle JL, Michel MC, Kay GG (2011) A comprehensive non-clinical evaluation of the CNS penetration potential of antimuscarinic agents for the treatment of overactive bladder. Br J Clin Pharmacol 72:235\u2013246","journal-title":"Br J Clin Pharmacol"},{"key":"910_CR6","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1111\/j.1755-5949.2011.00248.x","volume":"18","author":"M Chancellor","year":"2012","unstructured":"Chancellor M, Boone T (2012) Anticholinergics for overactive bladder therapy: central nervous system effects. CNS Neurosci Ther 18:167\u2013174","journal-title":"CNS Neurosci Ther"},{"key":"910_CR7","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1093\/jn\/105.8.1003","volume":"105","author":"F Chevallier","year":"1975","unstructured":"Chevallier F, S\u00e9rougne C, Champarnaud G (1975) Effect upon brain weight and cholesterol content of maintaining rats of various ages at constant weight. J Nutr 105:1003\u20131011","journal-title":"J Nutr"},{"key":"910_CR8","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1126\/science.6338589","volume":"219","author":"JT Coyle","year":"1983","unstructured":"Coyle JT, Price DL, DeLong MR (1983) Alzheimer\u2019s disease: a disorder of cortical cholinergic innervation. Sci 219:1184\u20131190","journal-title":"Sci"},{"key":"910_CR9","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1016\/0306-4522(87)90117-5","volume":"20","author":"SB Dunnett","year":"1987","unstructured":"Dunnett SB, Whishaw IQ, Jones GH, Bunch ST (1987) Behavioural, biochemical and histochemical effects of different neurotoxic amino acids injected into nucleus basalis magnocellularis of rats. Neuroscience 20:653\u2013669","journal-title":"Neuroscience"},{"key":"910_CR10","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1038\/jcbfm.1992.112","volume":"12","author":"L Gisselsson","year":"1992","unstructured":"Gisselsson L, Smith ML, Siesj\u00f6 BK (1992) Influence of preischemic hyperglycemia on osmolality and early postischemic edema in the rat brain. J Cereb Blood Flow Metab 12:809\u2013816","journal-title":"J Cereb Blood Flow Metab"},{"key":"910_CR11","doi-asserted-by":"crossref","first-page":"2258","DOI":"10.1016\/S0022-5347(05)64367-4","volume":"168","author":"O Ishizuka","year":"2002","unstructured":"Ishizuka O, Gu BJ, Yang ZX, Nishizawa O, Andersson KE (2002) Functional role of central muscarinic receptors for micturition in normal conscious rats. J Urol 168:2258\u20132262","journal-title":"J Urol"},{"key":"910_CR12","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/S0014-2999(03)01487-0","volume":"465","author":"K Isomae","year":"2003","unstructured":"Isomae K, Morimoto S, Hasegawa H, Morita K, Kamei J (2003) Effects of T-82, a novel acetylcholinesterase inhibitor, on impaired learning and memory in passive avoidance task in rats. Eur J Pharmacol 465:97\u2013103","journal-title":"Eur J Pharmacol"},{"key":"910_CR13","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1111\/j.1532-5415.1998.tb01006.x","volume":"46","author":"IR Katz","year":"1998","unstructured":"Katz IR, Sands LP, Bilker W, DiFilippo S, Boyce A, D\u2019Angelo K (1998) Identification of medications that cause cognitive impairment in older people: the case of oxybutynin chloride. J Am Geriatr Soc 46:8\u201313","journal-title":"J Am Geriatr Soc"},{"key":"910_CR14","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/j.eururo.2006.03.057","volume":"50","author":"G Kay","year":"2006","unstructured":"Kay G, Crook T, Rekeda L, Lima R, Ebinger U, Arguinzoniz M, Steel M (2006) Differential effects of the antimuscarinic agents darifenacin and oxybutynin ER on memory in older subjects. Eur Urol 50:317\u2013326","journal-title":"Eur Urol"},{"key":"910_CR15","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1007\/s11934-007-0046-0","volume":"8","author":"AP Klausner","year":"2007","unstructured":"Klausner AP, Steers WD (2007) Antimuscarinics for the treatment of overactive bladder: a review of central nervous system effects. Curr Urol Rep 8:441\u2013447","journal-title":"Curr Urol Rep"},{"key":"910_CR16","first-page":"92","volume":"57","author":"F Kobayashi","year":"2007","unstructured":"Kobayashi F, Yageta Y, Segawa M, Matsuzawa S (2007a) Effects of imidafenacin (KRP-197\/ONO-8025), a new anti-cholinergic agent, on muscarinic acetylcholine receptors. High affinities for M3 and M1 receptor subtypes and selectivity for urinary bladder over salivary gland. Arzneimittelforschung 57:92\u2013100","journal-title":"Arzneimittelforschung"},{"key":"910_CR17","first-page":"147","volume":"57","author":"F Kobayashi","year":"2007","unstructured":"Kobayashi F, Yageta Y, Yamazaki T, Wakabayashi E, Inoue M, Segawa M, Matsuzawa S (2007b) Pharmacological effects of imidafenacin (KRP-197\/ONO-8025), a new bladder selective anti-cholinergic agent, in rats. Comparison of effects on urinary bladder capacity and contraction, salivary secretion and performance in the Morris water maze task. Arzneimittelforschung 57:147\u2013154","journal-title":"Arzneimittelforschung"},{"key":"910_CR18","doi-asserted-by":"crossref","first-page":"489","DOI":"10.3143\/geriatrics.36.489","volume":"36","author":"S Mori","year":"1999","unstructured":"Mori S, Kojima M, Sakai Y, Nakajima K (1999) Bladder dysfunction in dementia patients showing urinary incontinence: evaluation with cystometry and treatment with propiverine hydrochloride. Nihon Ronen Igakkai Zasshi 36:489\u2013494","journal-title":"Nihon Ronen Igakkai Zasshi"},{"key":"910_CR19","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1248\/bpb.30.54","volume":"30","author":"A Ohtake","year":"2007","unstructured":"Ohtake A, Saitoh C, Yuyama H, Ukai M, Okutsu H, Noguchi Y, Hatanaka T, Suzuki M, Sato S, Sasamata M, Miyata K (2007) Pharmacological characterization of a new antimuscarinic agent, solifenacin succinate, in comparison with other antimuscarinic agents. Biol Pharm Bull 30:54\u201358","journal-title":"Biol Pharm Bull"},{"key":"910_CR20","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1254\/jphs.09R13FM","volume":"112","author":"A Ohtake","year":"2010","unstructured":"Ohtake A, Sato S, Sasamata M, Miyata K (2010) The forefront for novel therapeutic agents based on the pathophysiology of lower urinary tract dysfunction: ameliorative effect of solifenacin succinate (Vesicare), a bladder-selective antimuscarinic agent, on overactive bladder symptoms, especially urgency episodes. J Pharmacol Sci 112:135\u2013141","journal-title":"J Pharmacol Sci"},{"key":"910_CR21","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1254\/jjp.87.27","volume":"87","author":"T Oka","year":"2001","unstructured":"Oka T, Nakano K, Kirimoto T, Matsuura N (2001) Effects of antimuscarinic drugs on both urinary frequency and cognitive impairment in conscious, nonrestrained rats. Jpn J Pharmacol 87:27\u201333","journal-title":"Jpn J Pharmacol"},{"key":"910_CR22","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1007\/s11934-011-0198-9","volume":"12","author":"D Pagoria","year":"2011","unstructured":"Pagoria D, O\u2019Connor RC, Guralnick ML (2011) Antimuscarinic drugs: review of the cognitive impact when used to treat overactive bladder in elderly patients. Curr Urol Rep 12:351\u2013357","journal-title":"Curr Urol Rep"},{"key":"910_CR23","volume-title":"The rat brain in stereotaxic coordinates","author":"G Paxinos","year":"1986","unstructured":"Paxinos G, Watson C (1986) The rat brain in stereotaxic coordinates, 2nd edn. Academic, North Ryde","edition":"2"},{"key":"910_CR24","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1002\/ana.10639","volume":"54","author":"EK Perry","year":"2003","unstructured":"Perry EK, Kilford L, Lees AJ, Burn DJ, Perry RH (2003) Increased Alzheimer pathology in Parkinson\u2019s disease related to antimuscarinic drugs. Ann Neurol 54:235\u2013238","journal-title":"Ann Neurol"},{"key":"910_CR25","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1111\/j.1442-2042.2008.02109.x","volume":"15","author":"R Sakakibara","year":"2008","unstructured":"Sakakibara R, Uchiyama T, Yamanishi T, Kishi M (2008) Dementia and lower urinary dysfunction: with a reference to anticholinergic use in elderly population. Int J Urol 15:778\u2013788","journal-title":"Int J Urol"},{"issue":"4","key":"910_CR26","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1007\/s10286-013-0200-3","volume":"23","author":"R Sakakibara","year":"2013","unstructured":"Sakakibara R, Tateno F, Yano M, Takahashi O, Sugiyama M, Ogata T, Haruta H, Kishi M, Tsuyusaki Y, Yamamoto T, Uchiyama T, Yamanishi T, Yamaguchi C (2013) Imidafenacin on bladder and cognitive function in neurologic OAB patients. Clin Auton Res 23(4):189\u201395","journal-title":"Clin Auton Res"},{"key":"910_CR27","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1016\/j.clpt.2004.01.015","volume":"75","author":"EL Siegler","year":"2004","unstructured":"Siegler EL, Reidenberg M (2004) Treatment of urinary incontinence with anticholinergics in patients taking cholinesterase inhibitors for dementia. Clin Pharmacol Ther 75:484\u2013488","journal-title":"Clin Pharmacol Ther"},{"key":"910_CR28","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1111\/j.1442-2042.1994.tb00060.x","volume":"1","author":"T Sugiyama","year":"1994","unstructured":"Sugiyama T, Hashimoto K, Kiwamoto H, Ohnishi N, Esa A, Park YC, Kurita T (1994) Urinary incontinence in senile dementia of the Alzheimer type (SDAT). Int J Urol 1:337\u2013340","journal-title":"Int J Urol"},{"key":"910_CR29","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1007\/s002400050169","volume":"27","author":"T Sugiyama","year":"1999","unstructured":"Sugiyama T, Park YC, Kurita T (1999) Oxybutynin disrupts learning and memory in the rat passive avoidance response. Urol Res 27:393\u2013395","journal-title":"Urol Res"},{"key":"910_CR30","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1001\/archpsyc.1987.01800170032006","volume":"44","author":"T Sunderland","year":"1987","unstructured":"Sunderland T, Tariot PN, Cohen RM, Weingartner H, Mueller EA 3rd, Murphy DL (1987) Anticholinergic sensitivity in patients with dementia of the Alzheimer type and age-matched controls. A dose\u2013response study. Arch Gen Psychiatry 44:418\u2013426","journal-title":"Arch Gen Psychiatry"},{"key":"910_CR31","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/0006-8993(88)91227-9","volume":"472","author":"T Sunderland","year":"1988","unstructured":"Sunderland T, Tariot PN, Newhouse PA (1988) Differential responsivity of mood, behavior, and cognition to cholinergic agents in elderly neuropsychiatric populations. Brain Res 472:371\u2013389","journal-title":"Brain Res"},{"key":"910_CR32","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.ejphar.2006.11.054","volume":"557","author":"M Suzuki","year":"2007","unstructured":"Suzuki M, Noguchi Y, Okutsu H, Ohtake A, Sasamata M (2007) Effect of antimuscarinic drugs used for overactive bladder on learning in a rat passive avoidance response test. Eur J Pharmacol 557:154\u2013158","journal-title":"Eur J Pharmacol"},{"key":"910_CR33","doi-asserted-by":"crossref","first-page":"2274","DOI":"10.1056\/NEJM200312043492325","volume":"349","author":"JW Tsao","year":"2003","unstructured":"Tsao JW, Heilman KM (2003) Transient memory impairment and hallucinations associated with tolterodine use. N Engl J Med 349:2274\u20132275","journal-title":"N Engl J Med"},{"key":"910_CR34","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1523\/JNEUROSCI.14-01-00167.1994","volume":"14","author":"ML Voytko","year":"1994","unstructured":"Voytko ML, Olton DS, Richardson RT, Gorman LK, Tobin JR, Price DL (1994) Basal forebrain lesions in monkeys disrupt attention but not learning and memory. J Neurosci 14:167\u2013186","journal-title":"J Neurosci"},{"key":"910_CR35","first-page":"377","volume":"54","author":"WJ Wilson","year":"1994","unstructured":"Wilson WJ, Cook JA (1994) Cholinergic manipulations and passive avoidance in the rat: effects on acquisition and recall. Acta Neurobiol Exp (Wars) 54:377\u2013391","journal-title":"Acta Neurobiol Exp (Wars)"},{"key":"910_CR36","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1001\/archneur.60.5.771","volume":"60","author":"KB Womack","year":"2003","unstructured":"Womack KB, Heilman KM (2003) Tolterodine and memory: dry but forgetful. Arch Neurol 60:771\u2013773","journal-title":"Arch Neurol"},{"key":"910_CR37","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1124\/jpet.110.172288","volume":"336","author":"S Yamada","year":"2011","unstructured":"Yamada S, Seki M, Ogoda M, Fukata A, Nakamura M, Ito Y (2011) Selective binding of bladder muscarinic receptors in relation to the pharmacokinetics of a novel antimuscarinic agent, imidafenacin, to treat overactive bladder. J Pharmacol Exp Ther 336:365\u2013371","journal-title":"J Pharmacol Exp Ther"},{"key":"910_CR38","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.neuroimage.2011.06.031","volume":"58","author":"S Yamamoto","year":"2011","unstructured":"Yamamoto S, Maruyama S, Ito Y, Kawamata M, Nishiyama S, Ohba H, Yamada S, Tsukada H (2011) Effect of oxybutynin and imidafenacin on central muscarinic receptor occupancy and cognitive function: a monkey PET study with [(11)C](+)3-MPB. Neuroimage 58:1\u20139","journal-title":"Neuroimage"},{"key":"910_CR39","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1007\/s00210-011-0675-1","volume":"384","author":"T Yamazaki","year":"2011","unstructured":"Yamazaki T, Muraki Y, Anraku T (2011) In vivo bladder selectivity of imidafenacin, a novel antimuscarinic agent, assessed by using an effectiveness index for bladder capacity in rats. Naunyn Schmiedebergs Arch Pharmacol 384:319\u2013329","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"910_CR40","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.lfs.2010.06.008","volume":"87","author":"A Yoshida","year":"2010","unstructured":"Yoshida A, Maruyama S, Fukumoto D, Tsukada H, Ito Y, Yamada S (2010) Noninvasive evaluation of brain muscarinic receptor occupancy of oxybutynin, darifenacin and imidafenacin in rats by positron emission tomography. Life Sci 87:175\u2013180","journal-title":"Life Sci"}],"container-title":["Naunyn-Schmiedeberg's Archives of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00210-013-0910-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00210-013-0910-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00210-013-0910-z","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,7,22]],"date-time":"2019-07-22T17:12:00Z","timestamp":1563815520000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00210-013-0910-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,8,31]]},"references-count":40,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2013,12]]}},"alternative-id":["910"],"URL":"https:\/\/doi.org\/10.1007\/s00210-013-0910-z","relation":{},"ISSN":["0028-1298","1432-1912"],"issn-type":[{"value":"0028-1298","type":"print"},{"value":"1432-1912","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,8,31]]}}}